Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
36 results
D2.245 - Dithranol loaded Dendritic nanoarchitectures for the treatment of psoriasis
D2.246 - Occupational contact dermatitis to chromium in guitarist
D2.247 - Vitamin D Status as a Modifiable Factor in Chronic Spontaneous Urticaria
D2.249 - The impact of the coronavirus infection and vaccination against SARS-CoV-2 in the course of chronic urticaria
D2.251 - Allergic Contact Dermatitis to Clonidine Transdermal Patch: Insights From a Rare Case With Prolonged Cutaneous Exposure
D2.254 - Thyroid Autoantibody Seroconversion in Chronic Spontaneous Urticaria: Insights from Omalizumab Treated Patients
D2.255 - Adult-onset Still’s disease mimicking chronic spontaneous urticaria: a case report
D2.259 - Beyond Contact with Water: A Case of Aquagenic Urticaria
D2.250 - Sensitivity to Dental Materials and Its Clinical Implications: A Retrospective Patch Test Study
D2.248 - Asthma control in patients with moderate-to-severe atopic dermatitis and comorbid-asthma treated with lebrikizumab in a real-world-setting: interim analysis of the non-interventional study ADLife
D2.252 - Occupational Allergic Contact Dermatitis: Impact on Work Productivity and Professional Activity
D2.253 - Trends in Allergic Contact Dermatitis to Metals According to Gender
D2.256 - Aquagenic syringeal acrokeratoderma: a diagnostic challenge triggered by water exposure
D2.257 - Is It Beneficial To Expand The Allergy Test Panel Based On Component-Based Test Results In Chronic Urticaria?
D2.260 - The Burden of Chronic Urticaria
D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies
D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection
D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper
D2.450 - EUFOREA/EPOS Criteria Applied to a Diverse CRSwNP Cohort: Post Hoc Findings from Twice-Yearly depemokimab ANCHOR-1/-2 trials
D2.451 - Real-life upper and lower airway outcomes of long-term dupilumab treatment in patients with severe chronic rhinosinusitis with nasal polyps
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download